Results 281 to 290 of about 8,980,898 (399)

Screening for lung cancer: A systematic review of overdiagnosis and its implications

Molecular Oncology, EarlyView.
Low‐dose computed tomography (CT) screening for lung cancer may increase overdiagnosis compared to no screening, though the risk is likely low versus chest X‐ray. Our review of 8 trials (84 660 participants) shows added costs. Further research with strict adherence to modern nodule management strategies may help determine the extent to which ...
Fiorella Karina Fernández‐Sáenz, Laura de la Torre‐Perez, David R Baldwin, Carlijn van der Aalst, Mangesh Thorat, David Ritchie, Andre L Carvalho, Carolina Espina, Ivan Solà, Carlos Canelo‐Aybar, Moira Magdalena Pissinis, Pablo Alonso‐Coello, Ana Carolina Pereira Nunes Pinto   +12 more
wiley   +1 more source

Selective empathy and the genocide in Gaza: the silence of health and academic associations. [PDF]

Global Health
De Vogli R, Montomoli J, Wilkinson R, Pickett K.   +3 more
europepmc   +1 more source

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

Molecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece, Giulio Lovato, Ilaria Cela, Arianna Mercatelli, Benedetta Ferro, Jussi Nikkola, Sara Pagotto, Tommaso Grottola, Vincenzo De Laurenzi, Rossella Cicchetti, Antonio Marchetti, Luigi Schips, Rossano Lattanzio, Stefano Iacobelli, Emily Capone, Peter Black, Mads Daugaard, Michele Marchioni, Gianluca Sala   +18 more
wiley   +1 more source

Testing the applicability of a governance checklist for high-risk AI-based learning outcome assessment in Italian universities under the EU AI act annex III. [PDF]

Front Artif Intell
Manganello F, Nico A, Ragusa M, Boccuzzi G.   +3 more
europepmc   +1 more source

Study profile on baseline survey of Daiko Study in the Japan Multi-Institutional Collaborative Cohort Study (J-MICC Study).

, 2011
M. Emi, Nobuyuki Hamajima, Asahi Hishida, Kyoko Aoyama, Rieko Okada, Sayo Kawai, Koutaro Tomita, Sayaka Kuriki, Takashi Tamura, Mariko Naito, Takaaki Kondo, Jun Ueyama, Akiko Kimata, Kanami Yamamoto, Yoko Hori, Junko Hoshinos, Ritsuko Hamamotos, Sanae Tsukamoto, Joji Onishi, Shoichi Hagikura, Hisao Naito, Satoshi Hibi, Yoshinori Ito, Kenji Wakai   +23 more
openalex  

Institution within institution

The Annals of The Royal College of Surgeons of England
openaire   +1 more source

Survivin and Aurora Kinase A control cell fate decisions during mitosis

Molecular Oncology, EarlyView.
Aurora A interacts with survivin during mitosis and regulates its centromeric role. Loss of Aurora A activity mislocalises survivin, the CPC and BubR1, leading to disruption of the spindle checkpoint and triggering premature mitotic exit, which we refer to as ‘mitotic slippage’.
Hana Abdelkabir, Shalitha Wickrama Arachchige, Sally P. Wheatley   +2 more
wiley   +1 more source

Ethnic diversity in UK bioscience: Structural biases and recommendations for action. [PDF]

PLoS One
Siddiqui Y, Stafford P, Adukwu E, Freestone N, Joshi LT, Yhnell E, Hubbard K.   +6 more
europepmc   +1 more source

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

Molecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir, Lukasz Arcimowicz, Lucia Martinkova, Vaclav Hrabal, Filip Zavadil Kokas, Tomas Henek, Martina Kucerikova, Ondrej Bonczek, Pavlina Zatloukalova, Lenka Hernychova, Philip J. Coates, Borivoj Vojtesek, David P. Lane   +12 more
wiley   +1 more source

Exploring the links between NITAGs and academic institutions: a landscape analysis protocol. [PDF]

BMJ Open
Oduwole EO, Hussey GD, Hawkridge A, Noll S, Burton A, Sheridan SL, Kagina B.   +6 more
europepmc   +1 more source